Precede Biosciences
This role leads regulatory strategy and execution for US and global IVD products, managing end-to-end submissions and interactions with health authorities like the FDA. The position involves guiding companion diagnostic programs, shaping development plans, and ensuring submission-ready evidence for complex diagnostics. It requires embedding regulatory requirements into the quality system and managing regulatory risk in a growth-stage environment.
Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. Discover how we are helping create a world where medicine is developed more successfully, and every diagnosis is precise and minimally invasive.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Precede Biosciences.
Precede Biosciences didn’t post a salary, so this is our estimate from similar listings.